Blog

For many privately held Australian businesses, a valuation is not only needed for sale, restructuring, tax, or family law matters, it is also the foundation for insurance and buy-sell funding decisions. A properly prepared business valuation helps owners and advisers determine how much cover is appropriate to fund a share transfer, protect the enterprise if a shareholder dies or becomes disabled, and reduce the risk of disputes at a time of stress. In practice, the valuation is what converts an insurance discussion into an evidence-based funding strategy.

Why insurance funding should start with a valuation

Buy-sell agreements and key-person cover are often put in place with good intentions, but the cover amount is sometimes chosen by rough estimate rather than by reference to market value. That approach can leave the parties underinsured, overinsured, or exposed to a mismatch between the insurance proceeds and the amount actually required to complete a transfer or stabilise the business.

For Australian business owners, this matters because the value of a privately held business is not static. Earnings can move with economic cycles, interest rates, labour costs, customer concentration, and changes in demand. A valuation engagement provides a defensible estimate of market value at a specific date, supported by financial analysis and market evidence. That figure can then be used to size insurance cover that is commercially sensible and aligned with the business’s actual economics.

In a shareholder buyout, the valuation helps answer a simple question with significant consequences, how much should one owner, or the business, pay if an event forces a transfer? In a key-person context, the valuation helps quantify the economic loss if a critical individual is no longer available to generate revenue, retain customers, or maintain important relationships.

How valuation supports buy-sell funding arrangements

A buy-sell arrangement can be structured in different ways, including cross-purchase or entity-owned cover. Regardless of structure, the valuation is the anchor for the funding amount. It is usually built around the current market value of the business or the relevant equity interest, rather than an arbitrary figure that may have been set years earlier.

Where the agreement refers to a fixed price, the valuer still has a role because the owners need to know whether that fixed amount remains commercially reasonable. If the business has grown materially, or if profitability has weakened, a stale fixed price can become a source of dispute. Regular valuation updates help ensure the funding amount keeps pace with the business’s actual performance.

For privately held companies, valuation methodology commonly includes an earnings multiple approach, a discounted cash flow (DCF) analysis, or a combination of methods. A valuer may consider EBIT, EBITDA, or seller’s discretionary earnings (SDE), depending on the nature and size of the enterprise. For smaller owner-managed businesses, SDE may be more relevant because it captures the owner’s economic benefit after adding back discretionary and non-recurring expenses. For larger, more structured businesses, EBITDA and DCF are often more informative.

The valuation result is then used as a practical funding benchmark. If the business is worth $8 million on a controlling, going-concern basis, the level of insurance supporting a buyout must be judged against that value, while also allowing for tax, transaction costs, and any permitted funding mechanism under the agreement.

Why key-person cover also depends on valuation logic

Key-person insurance is often described as cover for the loss of an individual, but from a valuation perspective the relevant issue is the economic contribution that person makes to the business. That contribution may be direct revenue generation, technical expertise, access to supplier or customer relationships, strategic leadership, or the ability to win contracts. The valuation exercise helps quantify how dependent the business is on that person and what level of financial disruption would follow their absence.

For service businesses, professional firms, specialist trades, and founder-led enterprises, the dependency can be substantial. A business owner who drives most of the revenue may support margins well above the industry norm, but if a key person departs the valuation may need to reflect a lower maintainable earnings base. That in turn affects how much cover is required to preserve liquidity, recruit a replacement, retain customers, and protect enterprise value.

Valuation reasoning also matters where recurring revenue is central to the business model. In software, managed services, and subscription-based businesses, analysts often examine net revenue retention (NRR), churn, gross margin, and customer concentration. A business with strong NRR and low churn may justify a higher multiple and therefore a larger cover amount. By contrast, a business with unstable renewals or concentrated customer risk may have lower value and require a different level of protection.

Methodology: how a valuer approaches the funding amount

A valuation engagement for insurance or buy-sell funding begins with the same fundamentals as any market value exercise, normalised financial performance, sustainable earnings, capital structure, and market evidence. The valuer will typically review several years of financial statements, management accounts, budgets, and tax returns, then make adjustments for owner remuneration, related-party transactions, non-recurring items, and other factors that distort maintainable earnings.

From there, the valuer considers which methodology best reflects the business. Earnings multiples are common where there is sufficient market evidence from comparable transactions. DCF is often used where future cash flows are reasonably forecastable and the business has identifiable growth drivers. Revenue multiples are more common for early-stage or recurring-revenue businesses, although they must be applied carefully and only where sector evidence supports them. In practice, the stronger the basis for forecasting cash flow, the more reliable the valuation.

The capitalisation rate or discount rate is also critical. A valuer may build a weighted average cost of capital (WACC) for a business valuation, particularly in DCF work. That rate reflects the time value of money and the risk profile of the enterprise. If the business is volatile, highly leveraged, or heavily dependent on one customer or one individual, the discount rate rises and value falls. Where there is a lack of marketability or lack of control, discounts may also be relevant depending on the interest being valued and the purpose of the engagement.

For insurance funding, the distinction between enterprise value and equity value must be understood. A buy-sell arrangement may require the valuation of the whole business, a shareholder’s proportionate interest, or a specific class of shares. Debt, working capital needs, and shareholder loans must be considered so that the cover amount is matched to the real economic exposure.

Australian tax and regulatory considerations

Australian business owners should also consider how a valuation interacts with tax and regulatory issues. If a share transfer is triggered, Capital Gains Tax (CGT) may be relevant, and the small business CGT concessions can materially affect outcomes where eligibility conditions are met. In some cases, the 15-year exemption or the active asset rules may be significant. A valuation based on market value is often essential when determining the accounting and tax consequences of a transfer.

GST can also affect the structure of a business sale, including whether the transaction is treated as a going concern. Division 7A may be relevant where private company loans or shareholder advances are involved in a funding arrangement. A properly supported valuation helps advisers and owners avoid building an insurance strategy on assumptions that do not align with the broader transaction or tax position.

There is also a growing valuation need linked to superannuation. Division 296, which commenced on 1 July 2026, applies an additional tax to realised earnings attributable to a member’s Total Superannuation Balance between $3 million and $10 million, and a higher additional tax above $10 million. The thresholds are indexed, the tax is personal to the individual rather than the fund, and first assessments are issued in the 2027-28 year for the 2026-27 financial year. Importantly, the valuation relevance is direct, SMSFs holding business assets, business real property, or shares in a privately held company need current market valuations for Division 296 purposes, including where a cost base reset to market value at 30 June 2026 is available. That can create a separate and practical reason for a business owner to obtain a professional valuation.

Common mistakes in funding valuations

One common mistake is to rely on historical insurance formulas without reviewing current financial performance. A business may have doubled in value since the policy was first put in place, or it may have lost value through customer attrition, margin pressure, or reduced demand. Either way, stale cover creates avoidable risk.

Another mistake is to confuse book value with market value. Financial statements are important, but they do not, by themselves, determine the amount a prudent buyer would pay. Normalisation adjustments, sustainable earnings, and market evidence are what matter in a valuation engagement.

A third issue is failing to distinguish between a full valuation engagement and a limited scope valuation engagement or calculation engagement under APES 225 Valuation Services. For stakeholder agreements and insurance funding, the level of assurance should match the importance of the decision. A calculation engagement may be useful in some internal planning contexts, but where there is a potential dispute between shareholders, a more robust valuation engagement is often the wiser choice.

Finally, many owners overlook the need to update the valuation regularly. Annual or biennial reviews are often sensible, particularly where earnings are volatile, debt levels are changing, or the business is scaling quickly. That keeps cover aligned with reality rather than with outdated assumptions.

Conclusion

Insurance and buy-sell funding work properly only when the cover amount is grounded in a current, defensible valuation. For Australian business owners, that means understanding the business’s maintainable earnings, its growth prospects, its risk profile, and the market evidence supporting value. Whether the purpose is shareholder succession, key-person protection, tax planning, or superannuation compliance, the valuation is the foundation that turns a policy into a workable funding strategy.

If you would like a confidential discussion about a business valuation for insurance funding, buy-sell arrangements, or any other valuation engagement, contact InteleK Business Valuations & Advisory for professional support tailored to Australian private businesses.